The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Targeting renal fibrosis: Mechanisms and drug delivery systems
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., & Mi, S. (2015) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.02.001 · Cited by 1,901
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
The Extra Domain A of Fibronectin Activates Toll-like Receptor 4
Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., & Strauss, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100099200 · Cited by 1,216
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.1.2 · Cited by 1,057
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Hildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., & Ruoslahti, E. (1994) · Biochemical Journal · doi:10.1042/bj3020527 · Cited by 994
Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. (1992) · Nature · doi:10.1038/360361a0 · Cited by 974
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
Self-citationBasics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
Chakraborty, C., Sharma, A. R., Sharma, G., Doss, C. G. P., & Lee, S.-S. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.06.005 · Cited by 731
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Molecular basis of renal fibrosis
Eddy, A. A. (2000) · Pediatric Nephrology · doi:10.1007/s004670000461 · Cited by 637
Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns
Schaefer, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.619304 · Cited by 622
Self-citationPlasma and cellular fibronectin: distinct and independent functions during tissue repair
To, W. S., & Midwood, K. S. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-21 · Cited by 618
Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology
Murphy-Ullrich, J. E., & Poczatek, M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00029-5 · Cited by 586
Lipson, K. E., Wong, C., Teng, Y., & Spong, S. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 575
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562
Nielsen, R., Christensen, E. I., & Birn, H. (2016) · Kidney International · doi:10.1016/j.kint.2015.11.007 · Cited by 486
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
Babelova, A., Moreth, K., Tsalastra-Greul, W., Zeng-Brouwers, J., Eickelberg, O., Young, M. F., Bruckner, P., Pfeilschifter, J., Schaefer, R. M., Gröne, H.-J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014266 · Cited by 474
Self-citationEpithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
Kriz, W., Kaissling, B., & Le Hir, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44595 · Cited by 455
Abuissa, H., Jones, P. G., Marso, S. P., & O’Keefe, J. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.051 · Cited by 452
Preclinical and clinical development of siRNA-based therapeutics
Ozcan, G., Ozpolat, B., Coleman, R. L., Sood, A. K., & Lopez-Berestein, G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.007 · Cited by 449
Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule
Christensen, E. I., & Birn, H. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.4.f562 · Cited by 379
Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
Wang, B., Yao, K., Huuskes, B. M., Shen, H.-H., Zhuang, J., Godson, C., Brennan, E. P., Wilkinson-Berka, J. L., Wise, A. F., & Ricardo, S. D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.90 · Cited by 379
Transforming growth factor-β regulates production of proteoglycans by mesangial cells
Border, W. A., Okuda, S., Languino, L. R., & Ruoslahti, E. (1990) · Kidney International · doi:10.1038/ki.1990.35 · Cited by 363
Targeted drug delivery via folate receptors
Zhao, X., Li, H., & Lee, R. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.3.309 · Cited by 358
MicroRNAs in kidney physiology and disease
Trionfini, P., Benigni, A., & Remuzzi, G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.202 · Cited by 353
Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects
Sharma, P. C., Jain, A., Jain, S., Pahwa, R., & Yar, M. S. (2010) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903373350 · Cited by 353
Fibroblasts and myofibroblasts in renal fibrosis
Meran, S., & Steadman, R. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00764.x · Cited by 346
Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
Moestrup, S. K., Cui, S., Vorum, H., Bregengård, C., Bjørn, S. E., Norris, K., Gliemann, J., & Christensen, E. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118176 · Cited by 339
Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A., & Boor, P. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-4 · Cited by 337
Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333
Self-citationAnders, H.-J., & Schaefer, L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010117 · Cited by 330
Self-citationNew insights into form and function of fibronectin splice variants
White, E., Baralle, F., & Muro, A. (2008) · The Journal of Pathology · doi:10.1002/path.2388 · Cited by 323
Miyajima, A., Chen, J., Lawrence, C., Ledbetter, S., Soslow, R. A., Stern, J., Jha, S., Pigato, J., Lemer, M. L., Poppas, D. P., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00414.x · Cited by 321
Yamasaki, K., Muto, J., Taylor, K. R., Cogen, A. L., Audish, D., Bertin, J., Grant, E. P., Coyle, A. J., Misaghi, A., Hoffman, H. M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806084200 · Cited by 287
Dangers Within: DAMP Responses to Damage and Cell Death in Kidney Disease
Rosin, D. L., & Okusa, M. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040430 · Cited by 284
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
Voelker, J., Berg, P. H., Sheetz, M., Duffin, K., Shen, T., Moser, B., Greene, T., Blumenthal, S. S., Rychlik, I., Yagil, Y., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111230 · Cited by 275
Biological interplay between proteoglycans and their innate immune receptors in inflammation
Frey, H., Schroeder, N., Manon‐Jensen, T., Iozzo, R. V., & Schaefer, L. (2013) · The FEBS Journal · doi:10.1111/febs.12145 · Cited by 274
Self-citationThe next generation of therapeutics for chronic kidney disease
Breyer, M. D., & Susztak, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 272
Fibrosis Related Inflammatory Mediators: Role of the IL‐10 Cytokine Family
Sziksz, E., Pap, D., Lippai, R., Béres, N. J., Fekete, A., Szabó, A. J., & Vannay, Á. (2015) · Mediators of Inflammation · doi:10.1155/2015/764641 · Cited by 265
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
Karsdal, M. A., Manon-Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., Hansen, N.-U. B., Bay-Jensen, A.-C., Bager, C. L., Krag, A., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00447.2014 · Cited by 263
Trachtman, H., Fervenza, F. C., Gipson, D. S., Heering, P., Jayne, D. R. W., Peters, H., Rota, S., Remuzzi, G., Rump, L. C., Sellin, L. K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.33 · Cited by 263
Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury
Hamar, P., Song, E., Kökény, G., Chen, A., Ouyang, N., & Lieberman, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406421101 · Cited by 250
MacKinnon, M., Shurraw, S., Akbari, A., Knoll, G. A., Jaffey, J., & Clark, H. D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.077 · Cited by 246
Renal tubulointerstitial fibrosis: common but never simple
Hewitson, T. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90521.2008 · Cited by 246
Identification of a microRNA signature in renal fibrosis: role of miR-21
Zarjou, A., Yang, S., Abraham, E., Agarwal, A., & Liu, G. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00273.2011 · Cited by 241
Biglycan: A Multivalent Proteoglycan Providing Structure and Signals
Nastase, M. V., Young, M. F., & Schaefer, L. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412456380 · Cited by 238
Self-citationActivin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
Sugimoto, H., LeBleu, V. S., Bosukonda, D., Keck, P., Taduri, G., Bechtel, W., Okada, H., Carlson, W., Bey, P., Rusckowski, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2629 · Cited by 231
Goodall, K. J., Poon, I. K. H., Phipps, S., & Hulett, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109596 · Cited by 224
Xenon Preconditioning Protects against Renal Ischemic-Reperfusion Injury via HIF-1α Activation
Ma, D., Lim, T., Xu, J., Tang, H., Wan, Y., Zhao, H., Hossain, M., Maxwell, P. H., & Maze, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070712 · Cited by 210
Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy
Wang, S., Denichilo, M., Brubaker, C., & Hirschberg, R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00776.x · Cited by 208
Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., & Schaefer, L. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42213 · Cited by 207
Self-citationPhase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
Adler, S. G., Schwartz, S., Williams, M. E., Arauz-Pacheco, C., Bolton, W. K., Lee, T., Li, D., Neff, T. B., Urquilla, P. R., & Sewell, K. L. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09321209 · Cited by 204
The matricellular functions of small leucine-rich proteoglycans (SLRPs)
Merline, R., Schaefer, R. M., & Schaefer, L. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0066-2 · Cited by 200
Self-citationPotential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Chung, A. C.-K., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00050 · Cited by 180
Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases
Zhong, Y., Deng, Y., Chen, Y., Chuang, P. Y., & Cijiang He, J. (2013) · Kidney International · doi:10.1038/ki.2013.276 · Cited by 179
BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells
Wang, S., & Hirschberg, R. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00382.2002 · Cited by 177
Therapeutic targets for treating fibrotic kidney diseases
Lee, S.-Y., Kim, S. I., & Choi, M. E. (2015) · Translational Research · doi:10.1016/j.trsl.2014.07.010 · Cited by 176
Novel delivery system for natural products: Nano-curcumin formulations.
Rahimi, H. R., Nedaeinia, R., Shamloo, A. S., Nikdoust, S., & Oskuee, R. K. (2016) · Europe PMC (PubMed Central) · Cited by 176
Wang, B., Jha, J. C., Hagiwara, S., McClelland, A. D., Jandeleit-Dahm, K., Thomas, M. C., Cooper, M. E., & Kantharidis, P. (2014) · Kidney International · doi:10.1038/ki.2013.372 · Cited by 175
White, E. S., & Muro, A. F. (2011) · IUBMB Life · doi:10.1002/iub.493 · Cited by 174
Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
Schaefer, L., Tredup, C., Gubbiotti, M. A., & Iozzo, R. V. (2016) · FEBS Journal · doi:10.1111/febs.13963 · Cited by 168
Self-citationTreatment of Renal Fibrosis—Turning Challenges into Opportunities
Klinkhammer, B. M., Goldschmeding, R., Floege, J., & Boor, P. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.11.002 · Cited by 162
Schaefer, L., Macakova, K., Raslik, I., Micegova, M., Gröne, H.-J., Schönherr, E., Robenek, H., Echtermeyer, F. G., Grässel, S., Bruckner, P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64937-1 · Cited by 160
Self-citationSmall leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation
Moreth, K., Iozzo, R. V., & Schaefer, L. (2012) · Cell Cycle · doi:10.4161/cc.20316 · Cited by 158
Self-citationDolman, M. E. M., Harmsen, S., Storm, G., Hennink, W. E., & Kok, R. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.011 · Cited by 154
Interferon-γ inhibits experimental renal fibrosis
Oldroyd, S., Thomas, G. L., Gabbiani, G., & Nahas, A. M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00775.x · Cited by 150
Moreth, K., Frey, H., Hubo, M., Zeng-Brouwers, J., Nastase, M.-V., Hsieh, L. T.-H., Haceni, R., Pfeilschifter, J. M., Iozzo, R. V., & Schaefer, L. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.010 · Cited by 142
Self-citationExpression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney
Simon, M., Maresh, J. G., Harris, S. E., Hernandez, J. D., Arar, M. Y., Olson, M. S., & Abboud, H. E. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.3.f382 · Cited by 141
Dai, C., & Liu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130568.53923.fd · Cited by 141
TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis
Choi, M. E., Ding, Y., & Kim, S. I. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.003 · Cited by 138
Versatile role of heparanase in inflammation
Goldberg, R., Meirovitz, A., Hirshoren, N., Bulvik, R., Gallimidi, A. B., Rubinstein, A. M., & Elkin, M. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.02.008 · Cited by 136
Qiao, H., Sun, M., Su, Z., Xie, Y., Chen, M., Zong, L., Gao, Y., Li, H., Qi, J., Zhao, Q., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.106 · Cited by 125
Hydrodynamic Gene Delivery and Its Applications in Pharmaceutical Research
Bonamassa, B., Hai, L., & Liu, D. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0338-9 · Cited by 125
Smad7 Gene Therapy Ameliorates an Autoimmune Crescentic Glomerulonephritis in Mice
Ka, S., Huang, X., Lan, H.-Y., Tsai, P., Yang, S., Shui, H., & Chen, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080901 · Cited by 123
Vial, C., Gutiérrez, J., Santander, C., Cabrera, D., & Brandan, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189365 · Cited by 121
Kriegel, A. J., Fang, Y., Liu, Y., Tian, Z., Mladinov, D., Matus, I. R., Ding, X., Greene, A. S., & Liang, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq718 · Cited by 121
Ghosh, S. S., Gehr, T. W. B., & Ghosh, S. (2014) · Molecules · doi:10.3390/molecules191220139 · Cited by 120
Pirfenidone: an anti-fibrotic therapy for progressive kidney disease
Cho, M. E., & Kopp, J. B. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903501539 · Cited by 118
Gao, S., Hein, S., Dagnæs‐Hansen, F., Weyer, K., Yang, C., Nielsen, R., Christensen, E. I., Fenton, R. A., & Kjems, J. (2014) · Theranostics · doi:10.7150/thno.7866 · Cited by 115
Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics
Hong, C. A., & Nam, Y. S. (2014) · Theranostics · doi:10.7150/thno.8491 · Cited by 114
Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo
Morishita, Y., Imai, T., Yoshizawa, H., Watanabe, M., Ishibashi, K., Muto, S., & Nagata, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82587 · Cited by 110
The regulation and function of micrornas in kidney diseases
Wei, Q., Mi, Q., & Dong, Z. (2013) · IUBMB Life · doi:10.1002/iub.1174 · Cited by 104
Zhang, Z., Zheng, Q., Han, J., Gao, G., Liu, J., Gong, T., Gu, Z., Huang, Y., Sun, X., & He, Q. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.035 · Cited by 102
Supramolecular hydrogels as drug delivery systems.
Saboktakin, M., & Tabatabaei, R. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.02.006 · Cited by 100
In vitro anti-fibrotic activities of herbal compounds and herbs
Hu, Q., Noor, M., Wong, Y. F., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp245 · Cited by 100
Specific Renal Uptake of Randomly 50% N-Acetylated Low Molecular Weight Chitosan
Yuan, Z., Zhang, Z., Zhu, D., Sun, X., Gong, T., Liu, J., & Luan, C.-T. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800078a · Cited by 99
Effects of RAAS Inhibitors in Patients with Kidney Disease
Zhang, F., Liu, H., Liu, D., Liu, Y., Li, H., Tan, X., Liu, F., Peng, Y., & Zhang, H. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0771-9 · Cited by 98
Randomly 50%N-acetylated low molecular weight chitosan as a novel renal targeting carrier
Yuan, Z., Sun, X., Gong, T., Ding, H. Y., Fu, Y. S., & Zhang, Z. (2007) · Journal of drug targeting · doi:10.1080/10611860701289875 · Cited by 97
Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells
Wischnjow, A., Sarko, D., Janzer, M., Kaufman, C., Beijer, B., Brings, S., Haberkorn, U., Larbig, G., Kübelbeck, A., & Mier, W. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00057 · Cited by 95
Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis
Sun, X., Liu, Y., Li, C., Wang, X., Zhu, R., Liu, C., Liu, H., Wang, L., Ma, R., Fu, M., et al. (2017) · BioMed Research International · doi:10.1155/2017/2418671 · Cited by 94
Zeng-Brouwers, J., Beckmann, J., Nastase, M.-V., Iozzo, R. V., & Schaefer, L. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.12.003 · Cited by 92
Self-citationSoluble biglycan as a biomarker of inflammatory renal diseases
Hsieh, L. T.-H., Nastase, M.-V., Zeng-Brouwers, J., Iozzo, R. V., & Schaefer, L. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.07.020 · Cited by 90
Self-citationGeorge, J., Wang, S.-S., Sevcsik, A.-M., Sanicola, M., Cate, R. L., Koteliansky, V., & Bissell, D. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64711-6 · Cited by 89
Inhibitors/antagonists of TGF- system in kidney fibrosis
Yanagita, M. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs381 · Cited by 89
Schaefer, L., Tsalastra, W., Bábelová, A., Baliova, M., Minnerup, J., Sorokin, L. M., Gröne, H., Reinhardt, D. P., Pfeilschifter, J. M., Iozzo, R. V., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060497 · Cited by 88
Self-citationAdvances in Toll-like receptor biology: Modes of activation by diverse stimuli
Bryant, C. E., Gay, N. J., Heymans, S. R. B., Sacre, S. M., Schaefer, L., & Midwood, K. S. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1033511 · Cited by 85
Self-citationChang, C., Rossi, E. A., & Goldenberg, D. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1217 · Cited by 85
McVicker, B. L., & Bennett, R. G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00318 · Cited by 85
Kawelke, N., Vasel, M., Sens, C., von Au, A., Dooley, S., & Nakchbandi, I. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028181 · Cited by 84
Merline, R., Lazaroski, S., Bábelová, A., Tsalastra, W., Pfeilschifter, J. M., Schlüter, K., Günther, A., Iozzo, R. V., Schaefer, R. M., & Schaefer, L. (2009) · PubMed · Cited by 84
Self-citationDevelopment and in-vivo characterization of supramolecular hydrogels for intrarenal drug delivery.
Dankers, P., van Luyn, M. V., der Vlag, A. H.-V., Gemert, G. M. L. V., Petersen, A., Meijer, E. W., Janssen, H., Bosman, A., & Popa, E. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.052 · Cited by 82
Fibrosis in the kidney: is a problem shared a problem halved?
Hewitson, T. D. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s14 · Cited by 81
It has to be the αv: myofibroblast integrins activate latent TGF-β1
Hinz, B. (2013) · Nature Medicine · doi:10.1038/nm.3421 · Cited by 80
Role of bone morphogenetic protein-7 in renal fibrosis
Li, R. X., Yiu, W. H., & Tang, S. C. W. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00114 · Cited by 80
Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation
Gerarduzzi, C., Kumar, R. K., Trivedi, P., Ajay, A. K., Iyer, A., Boswell, S., Hutchinson, J. N., Waikar, S. S., & Vaidya, V. S. (2017) · JCI Insight · doi:10.1172/jci.insight.90299 · Cited by 79
Rodell, C. B., Rai, R., Faubel, S. G., Burdick, J. A., & Soranno, D. E. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.025 · Cited by 73
Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule
Jakob, C. G., Edalji, R. P., Judge, R. A., DiGiammarino, E. L., Li, Y., Gu, J., & Ghayur, T. (2013) · mAbs · doi:10.4161/mabs.23977 · Cited by 72
Soranno, D. E., Rodell, C. B., Altmann, C. J., Duplantis, J., Andrés-Hernando, A., Burdick, J. A., & Faubel, S. G. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00579.2015 · Cited by 71
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Bosukonda, D., Shih, M., Sampath, K. T., et al. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00362.x · Cited by 65
Megalin in acute kidney injury: foe and friend
Mahadevappa, R., Nielsen, R., Christensen, E., & Birn, H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00378.2013 · Cited by 64
Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis
Hsieh, L. T.-H., Frey, H., Nastase, M.-V., Tredup, C., Hoffmann, A., Poluzzi, C., Zeng-Brouwers, J., Manon‐Jensen, T., Schröder, K., Brandes, R. P., et al. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.12.005 · Cited by 59
Self-citationKushibiki, T., Nagata-Nakajima, N., Sugai, M., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.030 · Cited by 58
Ebid, R., Lichtnekert, J., & Anders, H. (2014) · ISRN Nephrology · doi:10.1155/2014/714081 · Cited by 58
Oroojalian, F., Rezayan, A. H., Mehrnejad, F., Nia, A. H., Shier, W. T., Abnous, K., & Ramezani, M. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.05.068 · Cited by 55
siRNAs targeted to Smad4 prevent renal fibrosis in vivo
Morishita, Y., Yoshizawa, H., Watanabe, M., Ishibashi, K., Muto, S., Kusano, E., & Nagata, D. (2014) · Scientific Reports · doi:10.1038/srep06424 · Cited by 47
Prakash, J., de Borst, M. H., van Loenen-Weemaes, A. M., Lacombe, M., Opdam, F., van Goor, H., Meijer, D. K. F., Moolenaar, F., Poelstra, K., & Kok, R. J. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9515-x · Cited by 46
Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin
Yuan, Z., Wu, X., Mo, J., Wang, Y., Xu, C., & Lim, L. Y. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.06.012 · Cited by 42
Baltatzi, M. S., Savopoulos, C., & Hatzitolios, A. I. (2011) · Europe PMC (PubMed Central) · Cited by 42
Next Generation Delivery System for Proteins and Genes of Therapeutic Purpose: Why and How?
Sharma, A. R., Kundu, S. K., Nam, J., Sharma, G., Doss, C. G. P., Lee, S., & Chakraborty, C. (2014) · BioMed Research International · doi:10.1155/2014/327950 · Cited by 42
Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney
Alan, C., Koçoğlu, H., Altıntaş, R., Alıcı, B., & Ersay, A. R. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.22069 · Cited by 40
Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells
Kok, R. J., Dolman, Harmsen, Pieters, Sparidans, Lacombe, Szokol, B., Őrfi, L., Kéri, Storm, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26485 · Cited by 40
Motojima, M., Matsusaka, T., Kon, V., & Ichikawa, I. (2009) · Nephron Experimental Nephrology · doi:10.1159/000254390 · Cited by 39
Tao, Y., Li, Y., Zheng, W., Zhao, J., Guo, M., Zhou, Y., Qin, N., Zheng, J., & Xu, L. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0228-7 · Cited by 39
Fu, Y., Lin, Q., Gong, T., Sun, X., & Zhang, Z. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.44 · Cited by 39
Triptolide attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction
Yuan, X., He, X., WANG, C., LIU, L., & Qian, F. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01359.x · Cited by 38
Synthesis and fragmentation of hyaluronan in renal ischaemia
Declèves, A., Caron, N., Voisin, V., Legrand, A., Bouby, N., Kultti, A. H., Tammi, M., & Flamion, B. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs098 · Cited by 38
Roles and regulation of bone morphogenetic protein-7 in kidney development and diseases
Tsujimura, T., Idei, M., Yoshikawa, M., Takase, O., & Hishikawa, K. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i9.288 · Cited by 38
Enhanced the oral bioavailability of salvianolic acid B by phospholipid complex loaded nanoparticles
Peng, Q., Gong, T., Zuo, J., et al. (2008) · Die Pharmazie · doi:10.31083/ph.2008.8053 · Cited by 37
Signaling at the Crossroads: Matrix-Derived Proteoglycan and Reactive Oxygen Species Signaling
Nastase, M.-V., Janicova, A., Wygrecka, M., & Schaefer, L. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7165 · Cited by 37
Self-citationHsieh, L. T.-H., Nastase, M.-V., Roedig, H., Zeng-Brouwers, J., Poluzzi, C., Schwalm, S. A., Fork, C., Tredup, C., Brandes, R. P., Wygrecka, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030595 · Cited by 36
Self-citationBone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis
Bramlage, C. P., Tampe, B., Koziolek, M. J., Maatouk, I., Bevanda, J., Bramlage, P., Ahrens, K., Lange, K., Schmid, H., Cohen, C. D., et al. (2010) · BMC Nephrology · doi:10.1186/1471-2369-11-31 · Cited by 35
Dolman, M. E. M., van Dorenmalen, K. M. A., Pieters, E. H. E., Lacombe, M., Pató, J., Storm, G., Hennink, W. E., & Kok, R. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.041 · Cited by 34
Delivery of RNAi therapeutics: work in progress
Miller, A. D. (2013) · Expert Review of Medical Devices · doi:10.1586/17434440.2013.855471 · Cited by 33
Adverse effects of drugs on the kidney
Bartoli, E. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.12.001 · Cited by 31
Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
Khaja, F., Jayawardena, D., Kuzmis, A., & Önyüksel, H. (2016) · Nanomaterials · doi:10.3390/nano6010008 · Cited by 30
Thuillier, R., Allain, G., Giraud, S., Saint-Yves, T., Delpech, P., Couturier, P., Billault, C., Marchand, E., Vaahtera, L., Parkkinen, J., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12661 · Cited by 27
Role of microRNA machinery in kidney fibrosis
Wang, B., & Ricardo, S. D. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12249 · Cited by 27
IL-18 induces profibrotic renal tubular cell injury via STAT3 activation
Matsui, F., Rhee, A. C., Hile, K. L., Zhang, H., & Meldrum, K. K. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00620.2012 · Cited by 25
Zhang, Z., Wu, F., Zheng, F., & Li, H. (2010) · Nephron Experimental Nephrology · doi:10.1159/000314669 · Cited by 23
Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies
Zeisberg, M., & Zeisberg, E. M. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0033-x · Cited by 21
Wang, G., Zhao, T., Wang, L., Hu, B., Darabi, A., Lin, J., Xing, M. M. Q., & Qiu, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07185 · Cited by 20
Nano-sized carriers in gene therapy for renal fibrosisin vivo
Miyazawa, H., Hirai, K., Ookawara, S., Ishibashi, K., & Morishita, Y. (2017) · Nano Reviews & Experiments · doi:10.1080/20022727.2017.1331099 · Cited by 14
Sun, J., Sun, Y., Wu, H., Zhang, H., Zhao, Z., Chen, Q., & Zhang, Z. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-451 · Cited by 12
Li, L., Wu, Y., Wang, C., & Zhang, W. (2012) · Renal Failure · doi:10.3109/0886022x.2012.723662 · Cited by 10
The source of myofibroblasts in kidney fibrosis
Allison, S. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.141 · Cited by 8
Hitching a ride to renal repair
Eirin, A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00589.2016 · Cited by 3
Cited by
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538
The extracellular matrix as a multitasking player in disease
Theocharis, A. D., Manou, D., & Karamanos, N. K. (2019) · The FEBS Journal · doi:10.1111/febs.14818 · Cited by 511
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Alle, Q., Le Borgne, E., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F., Bertrand‐Gaday, C., Pessemesse, L., Toupet, K., et al. (2022) · Aging Cell · doi:10.1111/acel.13714 · Cited by 66
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
Alle, Q., Le Borgne, E., Milhavet, O., & Lemaitre, J.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083990 · Cited by 35
Metadata
- Authors
- Nastase, M. V., Zeng-Brouwers, J., Wygrecka, M., & Schaefer, L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 129
- Pages
- 295-307
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2778815600
- Cited by
- 302
- References
- 162
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.